ERBB2 and small cell lung carcinoma: Downregulation of miR‐125b and miR‐125a by cytotoxic drugs could be the part of the mechanism in HER2 upregulation in SCLC and proposed a therapeutic strategy using trastuzumab in combination with cytotoxic drugs.14